Table 4.
Proportion of patients who tapered their dosage of inhaled corticosteroids in the montelukast add-on group
| |
Duration of treatment |
|||
|---|---|---|---|---|
| Baseline | 4 weeks | 8 weeks | 12 weeks | |
|
All patients |
328 |
320 |
197 |
288 |
|
Use of ICS, n |
|
|
|
|
| Yes |
252 |
245 |
159 |
220 |
| No |
76 |
75 |
38 |
68 |
|
Tapered ICS, n (%) |
|
|
|
|
| Yes* |
- |
45 (18.4) |
40 (25.2) |
44 (20.0) |
| No |
- |
194 (79.2) |
117 (73.6) |
175 (79.5) |
| Missing |
- |
6 (2.4) |
2 (1.3) |
1 (0.5) |
|
Preschool aged patients |
146 |
140 |
93 |
128 |
|
Use of ICS, n |
|
|
|
|
| Yes |
112 |
106 |
72 |
96 |
| No |
34 |
34 |
21 |
32 |
|
Tapered ICS, n (%) |
|
|
|
|
| Yes† |
- |
21 (19.8) |
20 (27.8) |
19 (19.8) |
| No |
- |
82 (77.4) |
50 (69.4) |
76 (79.2) |
| Missing |
- |
3 (2.8) |
2 (2.8) |
1 (1.0) |
|
School aged patients |
182 |
180 |
104 |
160 |
|
Use of ICS, n |
|
|
|
|
| Yes |
140 |
139 |
87 |
124 |
| No |
42 |
41 |
17 |
36 |
|
Tapered ICS, n (%) |
|
|
|
|
| Yes‡ |
- |
24 (17.3) |
20 (23.0) |
25 (20.2) |
| No |
- |
112 (80.6) |
67 (77.0) |
99 (79.8) |
| Missing | - | 3 (2.2) | 0 (0.0) | 0 (0.0) |
*There were 45 patients who newly tapered their ICS at 4 weeks, 17 at 8 weeks and 9 at 12 weeks.
†There were 21 preschool aged patients who newly tapered their ICS at 4 weeks, 8 at 8 weeks and 3 at 12 weeks.
‡There were 24 school aged patients who newly tapered their ICS at 4 weeks, 9 at 8 weeks and 6 at 12 weeks.